黄金城游戏

Tecan and laboratory software specialist Ugen T ec have announced a collaboration to develop fully integrated, sample-to-result solutions for PCR workflows. This newly formed partnership will combine Tecan’s liquid handling and automation expertise with Ugen T ec’s best-in-class FastFinder software , integrating end-to-end automation with comprehensive data analysis and workflow tools , provid ing high throughput solutions for molecular testing.

The COVID-19 pandemic has highlighted the challenges associated with high throughput molecular testing, requiring a more integrated approach to meet workload demands without compromising on the quality of results. Tecan and Ugen T ec will overcome this issue by creating a fully automated workflow – from sample preparation to data analysis and interpretation – using Tecan’s automation workstations with Ugen T ec’s FastFinder software suite . The joint solutions will be offered directly to diagnostics labs globally, as well as forming the basis of OEM in vitro diagnostics platforms developed through Tecan Synergence™.

Ralf Griebel, Head of Partnering Business at Tecan, commented: “This partnership with Ugen T ec is another important milestone in our growing digital ecosystem. We strongly believe that open innovation is the best way to provide labs with powerful solutions to meet the challenges they face today, an d to better prepare them for the future, and Ugen T ec’s forward-thinking approach and leading position in molecular diagnostics made the company a natural fit.”

Michiel Reessink , VP of Global Sales at UgenTec, added: “ Efficient automation is now essential for molecular diagnostics labs to attain the throughput and traceability necessary to meet international quality and compliance standards. The combination of our diagnostics-oriented artificial intelligence tools with Tecan’s market-leading liquid handling technologies provides the perfect end-to-end solution, helping labs to achieve the accuracy and scalability required to address current and future challenges in molecular diagnostics .”

To learn more about the Tecan’s offering in Genomics , visit diagnostics.tecan.com/molecular-genetics

About Tecan

Teca n ( www. tecan.com ) is a leading global provider of laboratory 黄金城游戏s and solutions in biop ha rmaceuticals, forensics and clinica l diagnostics. The company specializes i n the development, production and distribution o f autom ated workflow solutions for laborato ries in the 黄金城游戏s sector. Its clients include pharmaceutical an d biotechnology c om panies, university research departm ents, forensic and diagnost ic laboratori es. As an original 黄金城游戏 manufacturer (OEM), Tecan is also a leader in developing and m anufacturing OEM 黄金城游戏s and components that are then distributed b y partner compani es . Founded in Switzerland in 1980, t he company has manufacturin g, research a nd development sites in both Europe and North Am erica a nd maintains a 黄金城游戏 and service net work in 52 countries. In 2019, Tecan generated 黄金城游戏 of CHF 637 million (USD 643 million ; EUR 574 million). Registered shares of Tecan Grou p are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

Über Tecan

Tecan ( www.tecan.com ) ist ein weltweit führender Anbieter von Labor黄金城游戏en und Lösunge n für die Branchen Biopharm a, Forensik und Klinische Diagnostik. Das Unternehmen ist auf Entwicklung, Herstellung und Vertrieb von Automatisierungslösungen für Labora tori en im Life-Science-Bereich spezialisiert. Die Kunden von Tecan sind Pharma- und Biotec hnologieunternehmen, Forsch ungs-abteilungen von Universitäten sowie forensische und diagnostische Laboratorien. Als Originalgeräte-hersteller (OEM) ist Tecan auch füh rend in der Entwicklung und Herstellung von OEM-Instrumenten und Komponenten, die vom jewe iligen Partnerunternehmen v ertrieben werden. Tecan wurde 1980 in der Schweiz geg ründet. Das Unternehmen verfügt über Produktions-, Forschungs- und Entwicklungs-stätte n in Europa und in Nordamerika. In 52 Ländern unterhält es ein Vertriebs- und Servicenetz. Im Jahr 201 9 erzielte Teca n einen Umsatz von CHF 637 Mio. (USD 6 43 Mio.; EUR 5 7 4 Mio.). Die Namenaktien der Tecan Group werden an der SIX Swiss Exchange gehandelt (T ECN; ISIN CH0012100191).

About UgenTec

UgenTec ( www.ugentec.com ) is a leading molecular laboratory software provider servicing molecular diagnostics labs and assay providers globally across clinical, animal and agbio applications. Its FastFinder software platform is a modular, clinical-grade Software-as-a-Service solution that allows labs of all sizes to standardize and automate their molecular testing workflows. UgenTec’s FastFinder platf orm applies Artificial Intelligence to automate data analysis from sample to result, track and trace samples across the entire assay menu and 黄金城游戏 fleet, and provide the lab with valuable real-time insights in quality and lab operations. FastFinder’s modules include Workflow, Analysis, Insights and Workflow.